A9506 |
Tc-99m graphite crucible |
Cyclomedica Australia PTY Limited |
73814-0986-20 |
Technegas |
EACH |
1 |
50 |
50 |
50 |
A9513 |
Lutetium lu 177 dotatat ther |
Advanced Accelerator Applications USA, Inc. |
69488-0003-01 |
Lutathera |
1 mCi |
20 |
1 |
200 |
200 |
A9543 |
Y90 ibritumomab, rx |
Acrotech Biopharma LLC |
72893-0007-04 |
Zevalin Y-91 |
UP TO 40 millicuries |
1 |
1 |
1 |
1 |
A9582 |
Iodine i-123 iobenguane |
GE Healthcare Inc. |
17156-0235-01 |
Adreview |
UP TO 15 millicuries |
5 |
1 |
1 |
1 |
A9584 |
Iodine i-123 ioflupane |
GE Healthcare Inc. |
17156-0210-01 |
Datscan |
Per Study Dose, up to 5 millicuries |
2.5 |
1 |
1 |
1 |
A9586 |
Florbetapir f18 |
Eli Lilly and Company |
00002-1200-01 |
Amyvid |
UP TO 10 mCi |
10 |
1 |
1 |
1 |
A9587 |
Gallium ga-68 |
Advanced Accelerator Applications USA, Inc. |
69488-0001-40 |
Netspot |
0.1 mCi |
1 |
1 |
1 |
1 |
A9588 |
Fluciclovine f-18 |
Blue Earth Diagnostics Limited |
69932-0001-01 |
Axumin |
1 mCi |
1 |
1 |
1 |
1 |
A9591 |
Fluoroestradiol f 18 |
GE Healthcare Inc. |
72874-0001-01 |
Cerianna |
1 mCi |
50 |
1 |
6 |
6 |
A9592 |
Copper cu 64 dotatate diag |
Curium US LLC |
69945-0064-01 |
Detectnet |
1 mCi |
4 |
1 |
4 |
4 |
A9593 |
Gallium ga-68 psma-11 ucsf |
UCSF Radiopharmaceutical Facility |
24275-0525-01 |
Gallium Ga 68 PSMA |
1 mCi |
11 |
1 |
1 |
1 |
A9594 |
Gallium ga-68 psma-11, ucla |
UCLA Biomedical Cyclotron |
76394-2642-03 |
Gallium Ga 68 PSMA |
1 mCi |
12 |
1 |
1 |
1 |
A9595 |
Piflu f-18, dia 1 millicurie |
Progenics Pharmaceuticals, Inc. |
71258-0022-00 |
Pylarify |
1 millicurie |
1 |
1 |
9 |
9 |
A9595 |
Piflu f-18, dia 1 millicurie |
Progenics Pharmaceuticals, Inc. |
71258-0022-01 |
Pylarify |
1 mCi |
50 |
1 |
1 |
1 |
A9596 |
Gallium illuccix 1 millicure |
Telix Pharmaceuticals US Inc. |
74725-0100-25 |
Illuccix |
1 mCi |
1 |
1 |
1 |
1 |
A9596 |
Gallium illuccix 1 millicure |
Telix Pharmaceuticals US Inc. |
74725-0100-64 |
Illuccix |
1 mCi |
1 |
1 |
1 |
1 |
A9600 |
Sr89 strontium |
Q Biomed Inc |
72928-0089-01 |
Strontium Chloride Sr 89 |
PER MILLICURIE |
4 |
1 |
1 |
4 |
A9601 |
Flortaucipir inj 1 millicuri |
Eli Lilly and Company |
00002-1220-01 |
Tauvid |
1 mCi |
1 |
1 |
1 |
1 |
A9602 |
Fluorodopa f-18 diag per mci |
The Feinstein Institute for Medical Research |
13267-0346-57 |
Fluorodopa F18 |
1 mCi |
1 |
1 |
1 |
1 |
A9606 |
Radium ra223 dichloride ther |
Bayer HealthCare Pharmaceuticals Inc. |
50419-0208-01 |
Xofigo |
1 mCi |
6 |
1 |
1 |
1 |
A9607 |
Lutetium lu 177 vipivotide |
Advanced Accelerator Applications USA, Inc. |
69488-0010-61 |
Pluvicto |
1 mCi |
1 |
1 |
1 |
1 |
A9608 |
Flotufolastat f18 diag 1 mci |
Blue Earth Diagnostics Limited |
69932-0002-01 |
Posluma |
1 mCi |
1 |
1 |
1 |
8 |
A9608 |
Flotufolastat f18 diag 1 mci |
Blue Earth Diagnostics Limited |
69932-0002-50 |
Posluma |
1 millicurie |
25 |
1 |
1 |
1 |
A9611 |
Flurpiridaz f18, diag, 1 mci |
GE Healthcare Inc. |
00407-8787-01 |
Flyrcado |
1 mCi |
1 |
1 |
1 |
1 |
A9615 |
Inj, pegulicianine, 1 mg |
Lumicell, Inc. |
82292-0040-10 |
Lumisight |
1 MG |
1 |
10 |
39 |
390 |
A9616 |
Gallium gozellix 1 millicuri |
Telix Innovations SA |
84552-0500-25 |
Gozellix |
1 MCI |
1 |
1 |
1 |
1 |
A9616 |
Gallium gozellix 1 millicuri |
Telix Innovations SA |
84552-0500-64 |
Gozellix |
1 MCI |
1 |
1 |
1 |
1 |
A9697 |
Inj, magtrace per study dose |
Endomagnetics Inc. |
60391-021024 |
Magtrace |
PER STUDY DOSE |
2 |
10 |
1 |
1 |
A9800 |
Gallium locametz 1 millicuri |
Advanced Accelerator Applications USA, Inc. |
69488-0017-61 |
Locametz |
1 mCi |
1 |
1 |
1 |
1 |
C9047 |
Injection, caplacizumab-yhdp |
Genzyme Corporation |
58468-0225-01 |
Cablivi |
1 MG |
1 |
1 |
11 |
11 |
C9250 |
Artiss fibrin sealant |
Baxter Healthcare Corporation |
00338-9637-01 |
Artiss |
2 ML |
2 |
1 |
1 |
1 |
C9250 |
Artiss fibrin sealant |
Baxter Healthcare Corporation |
00338-9639-01 |
Artiss |
2 ML |
4 |
1 |
2 |
2 |
C9250 |
Artiss fibrin sealant |
Baxter Healthcare Corporation |
00338-9641-01 |
Artiss |
2 ML |
10 |
1 |
5 |
5 |
C9257 |
Bevacizumab injection |
Genentech, Inc. |
50242-0060-01 |
Avastin |
0.25 MG |
4 |
1 |
400 |
400 |
C9257 |
Bevacizumab injection |
Genentech, Inc. |
50242-0061-01 |
Avastin |
0.25 MG |
16 |
1 |
1600 |
1600 |
C9293 |
Injection, glucarpidase |
BTG International Inc. |
50633-0210-11 |
Voraxaze |
10 UNITS |
1 |
1 |
100 |
100 |
C9460 |
Injection, cangrelor |
Chiesi USA, Inc. |
10122-0620-10 |
Kengreal |
1 MG |
1 |
10 |
50 |
500 |
C9482 |
Sotalol hydrochloride iv |
Altathera Pharmaceuticals, LLC |
69724-0112-10 |
Sotalol |
1 MG |
10 |
1 |
150 |
150 |
J0184 |
Inj, amisulpride, 1 mg |
Acacia Pharma Ltd |
71390-0125-20 |
Barhemsys |
1 MG |
2 |
10 |
5 |
50 |
J0184 |
Inj, amisulpride, 1 mg |
Acacia Pharma Ltd |
71390-0125-50 |
Barhemsys |
1 MG |
4 |
10 |
10 |
100 |
J0208 |
Inj, pedmark, 100 mg |
Fennec Pharmaceuticals, Inc. |
73077-0010-01 |
Sodium Thiosulfate |
100 MG |
100 |
1 |
125 |
125 |
J0209 |
Inj, sod thiosulfate (hope) |
Hope Pharmaceuticals |
60267-0705-50 |
Sodium Thiosulfate (Hope) |
100 MG |
50 |
1 |
125 |
125 |
J0211 |
Inj, nithiodote, 3mg / 125mg |
Hope Pharmaceuticals |
60267-0812-00 |
Nithiodote |
3 MG AND 125 MG |
60 |
1 |
100 |
100 |
J0391 |
Inj, artesunate, 1mg |
Amivas, Inc |
73607-0011-11 |
Artesunate |
1 MG |
1 |
2 |
110 |
220 |
J0567 |
Inj., cerliponase alfa 1 mg |
BioMarin Pharmaceutical Inc. |
68135-0811-02 |
Brineura |
1 MG |
1 |
2 |
150 |
300 |
J0606 |
Inj, etelcalcetide, 0.1 mg |
Amgen Inc |
55513-0740-10 |
Parsabiv |
0.1 MG |
0.5 |
10 |
25 |
250 |
J0606 |
Inj, etelcalcetide, 0.1 mg |
Amgen Inc |
55513-0741-10 |
Parsabiv |
0.1 MG |
1 |
10 |
50 |
500 |
J0606 |
Inj, etelcalcetide, 0.1 mg |
Amgen Inc |
55513-0742-10 |
Parsabiv |
0.1 MG |
2 |
10 |
100 |
1000 |
J0654 |
Inj, liothyronine, 1 mcg |
XGen Pharmaceuticals DJB, Inc. |
39822-0151-01 |
Liothyronine Sodium |
1 MCG |
1 |
1 |
10 |
10 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0301-02 |
Zynrelef |
1 MG - 0.03 MG |
14 |
1 |
400 |
400 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0303-01 |
Zynrelef |
1 MG - 0.03 MG |
7 |
1 |
200 |
200 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0501-02 |
Zynrelef |
1 MG - 0.03 MG |
14 |
1 |
400 |
400 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0503-01 |
Zynrelef |
1 MG - 0.03 MG |
7 |
1 |
200 |
200 |
J0675 |
Inj, carboprost, 0.1 mg |
Pfizer Inc |
00409-0064-10 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Dr. Reddy's Laboratories Inc. |
43598-0179-10 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Dr. Reddy's Laboratories Inc. |
43598-0698-58 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
NOVAPLUS/DR.REDDY'S |
43598-0917-58 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Dr Reddy'S Laboratories, Inc. |
43598-0919-58 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Eugia US LLC |
55150-0459-10 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Alembic Pharmaceuticals Inc. |
62332-0777-10 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
FreseniUS Kabi USA, LLC |
65219-0579-01 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Amneal Pharmaceuticals, LLC |
70121-1680-07 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Sola Pharmaceuticals |
70512-0859-05 |
Carboprost Tromethamine |
0.1 MG |
1 |
5 |
2.5 |
12.5 |
J0675 |
Inj, carboprost, 0.1 mg |
Xellia Pharmaceuticals USA, LLC. |
70594-0112-02 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
BE Pharmaceuticals Inc. |
71839-0137-10 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Long Grove Pharmaceuticals, LLC |
81298-5010-03 |
Carboprost Tromethamine |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0675 |
Inj, carboprost, 0.1 mg |
Long Grove Pharmaceuticals, LLC |
81298-5010-05 |
Carboprost Tromethamine |
0.1 MG |
1 |
1 |
2.5 |
2.5 |
J0675 |
Inj, carboprost, 0.1 mg |
Pfizer Inc |
00009-0856-08 |
Hemabate |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0681 |
Inj ceftobipole medocarl 3mg |
La Jolla Pharmaceutical Company |
68547-0578-10 |
Zevtera |
3 MG |
1 |
10 |
222.333333333333 |
2224 |
J0891 |
Argatroban nonesrd (accord) |
Accord Healthcare Inc |
16729-0430-43 |
Argatroban |
1 MG |
50 |
10 |
50 |
500 |
J0911 |
Inst tauro 1.35mg/hep 100u |
CorMedix Inc. |
72990-0103-10 |
Defencath |
taurolidine 1.35 mg and heparin sodium 100 units |
3 |
10 |
30 |
300 |
J1073 |
Testosterone pellet 75 mg |
Endo USA, Inc. |
66887-0004-10 |
Testopel |
75 MG |
1 |
10 |
1 |
10 |
J1073 |
Testosterone pellet 75 mg |
Endo USA, Inc. |
66887-0004-20 |
Testopel |
75 MG |
1 |
100 |
1 |
100 |
J1097 |
Phenylep ketorolac opth soln |
Omeros Corporation |
62225-0600-04 |
Omidria |
1 ML |
4 |
4 |
4 |
16 |
J1097 |
Phenylep ketorolac opth soln |
Rayner Surgical Inc. |
82604-0600-04 |
Omidria |
1 ML |
4 |
4 |
4 |
16 |
J1327 |
Eptifibatide injection |
Baxter Healthcare Corporation |
00338-9558-10 |
Eptifibatide |
5 MG |
100 |
12 |
15 |
180 |
J1327 |
Eptifibatide injection |
Sagent Pharmaceuticals |
25021-0408-51 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Sagent Pharmaceuticals |
25021-0409-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Eugia US LLC |
55150-0218-99 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Eugia US LLC |
55150-0219-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Eugia US LLC |
55150-0220-99 |
Eptifibatide |
5 MG |
100 |
1 |
40 |
40 |
J1327 |
Eptifibatide injection |
Mylan Institutional LLC |
67457-0629-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Mylan Institutional LLC |
67457-0630-10 |
Eptifibatide |
5 MG |
100 |
1 |
40 |
40 |
J1327 |
Eptifibatide injection |
Mylan Institutional LLC |
67457-0631-10 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Slate Run Pharmaceuticals |
70436-0026-80 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Slate Run Pharmaceuticals |
70436-0027-80 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Slate Run Pharmaceuticals |
70436-0162-80 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Slate Run Pharmaceuticals |
70436-0163-80 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Athenex Pharmaceutical Division, LLC |
70860-0303-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Athenex Pharmaceutical Division, LLC |
70860-0305-51 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Meitheal Pharmaceuticals Inc. |
71288-0412-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Meitheal Pharmaceuticals Inc. |
71288-0413-51 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Mylan Institutional LLC |
72078-0025-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
Mylan Institutional LLC |
72078-0026-10 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
Mylan Institutional LLC |
72078-0027-10 |
Eptifibatide |
5 MG |
100 |
1 |
40 |
40 |
J1327 |
Eptifibatide injection |
Avenacy Inc. |
83634-0301-51 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0100-10 |
Hemgenix |
Per Therapeutic Dose |
10 |
10 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0110-11 |
Hemgenix |
Per Therapeutic Dose |
10 |
11 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0120-12 |
Hemgenix |
Per Therapeutic Dose |
10 |
12 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0130-13 |
Hemgenix |
Per Therapeutic Dose |
10 |
13 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0140-14 |
Hemgenix |
Per Therapeutic Dose |
10 |
14 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0150-15 |
Hemgenix |
Per Therapeutic Dose |
10 |
15 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0160-16 |
Hemgenix |
Per Therapeutic Dose |
10 |
16 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0170-17 |
Hemgenix |
Per Therapeutic Dose |
10 |
17 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0180-18 |
Hemgenix |
Per Therapeutic Dose |
10 |
18 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0190-19 |
Hemgenix |
Per Therapeutic Dose |
10 |
19 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0200-20 |
Hemgenix |
Per Therapeutic Dose |
10 |
20 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0210-21 |
Hemgenix |
Per Therapeutic Dose |
10 |
21 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0220-22 |
Hemgenix |
Per Therapeutic Dose |
10 |
22 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0230-23 |
Hemgenix |
Per Therapeutic Dose |
10 |
23 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0240-24 |
Hemgenix |
Per Therapeutic Dose |
10 |
24 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0250-25 |
Hemgenix |
Per Therapeutic Dose |
10 |
25 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0260-26 |
Hemgenix |
Per Therapeutic Dose |
10 |
26 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0270-27 |
Hemgenix |
Per Therapeutic Dose |
10 |
27 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0280-28 |
Hemgenix |
Per Therapeutic Dose |
10 |
28 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0290-29 |
Hemgenix |
Per Therapeutic Dose |
10 |
29 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0300-30 |
Hemgenix |
Per Therapeutic Dose |
10 |
30 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0310-31 |
Hemgenix |
Per Therapeutic Dose |
10 |
31 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0320-32 |
Hemgenix |
Per Therapeutic Dose |
10 |
32 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0330-33 |
Hemgenix |
Per Therapeutic Dose |
10 |
33 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0340-34 |
Hemgenix |
Per Therapeutic Dose |
10 |
34 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0350-35 |
Hemgenix |
Per Therapeutic Dose |
10 |
35 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0360-36 |
Hemgenix |
Per Therapeutic Dose |
10 |
36 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0370-37 |
Hemgenix |
Per Therapeutic Dose |
10 |
37 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0380-38 |
Hemgenix |
Per Therapeutic Dose |
10 |
38 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0390-39 |
Hemgenix |
Per Therapeutic Dose |
10 |
39 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0400-40 |
Hemgenix |
Per Therapeutic Dose |
10 |
40 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0410-41 |
Hemgenix |
Per Therapeutic Dose |
10 |
41 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0420-42 |
Hemgenix |
Per Therapeutic Dose |
10 |
42 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0430-43 |
Hemgenix |
Per Therapeutic Dose |
10 |
43 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0440-44 |
Hemgenix |
Per Therapeutic Dose |
10 |
44 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0450-45 |
Hemgenix |
Per Therapeutic Dose |
10 |
45 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0460-46 |
Hemgenix |
Per Therapeutic Dose |
10 |
46 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0470-47 |
Hemgenix |
Per Therapeutic Dose |
10 |
47 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0480-48 |
Hemgenix |
Per Therapeutic Dose |
10 |
48 |
1 |
1 |
J1412 |
Inj roctavian ml 2x10^13vc g |
BioMarin Pharmaceutical Inc. |
68135-0927-48 |
Roctavian |
1 ML |
8 |
1 |
8 |
8 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0503-12 |
Elevidys |
Per Therapeutic Dose |
1 |
12 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0505-14 |
Elevidys |
Per Therapeutic Dose |
1 |
14 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0506-15 |
Elevidys |
Per Therapeutic Dose |
1 |
15 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0507-16 |
Elevidys |
Per Therapeutic Dose |
1 |
16 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0508-17 |
Elevidys |
Per Therapeutic Dose |
1 |
17 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0509-18 |
Elevidys |
Per Therapeutic Dose |
1 |
18 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0510-19 |
Elevidys |
Per Therapeutic Dose |
1 |
19 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0511-20 |
Elevidys |
Per Therapeutic Dose |
1 |
20 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0512-21 |
Elevidys |
Per Therapeutic Dose |
1 |
21 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0513-22 |
Elevidys |
Per Therapeutic Dose |
1 |
22 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0514-23 |
Elevidys |
Per Therapeutic Dose |
1 |
23 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0515-24 |
Elevidys |
Per Therapeutic Dose |
1 |
24 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0516-25 |
Elevidys |
Per Therapeutic Dose |
1 |
25 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0517-26 |
Elevidys |
Per Therapeutic Dose |
1 |
26 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0518-27 |
Elevidys |
Per Therapeutic Dose |
1 |
27 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0519-28 |
Elevidys |
Per Therapeutic Dose |
1 |
28 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0520-29 |
Elevidys |
Per Therapeutic Dose |
1 |
29 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0521-30 |
Elevidys |
Per Therapeutic Dose |
1 |
30 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0522-31 |
Elevidys |
Per Therapeutic Dose |
1 |
31 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0523-32 |
Elevidys |
Per Therapeutic Dose |
1 |
32 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0524-33 |
Elevidys |
Per Therapeutic Dose |
1 |
33 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0525-34 |
Elevidys |
Per Therapeutic Dose |
1 |
34 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0526-35 |
Elevidys |
Per Therapeutic Dose |
1 |
35 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0527-36 |
Elevidys |
Per Therapeutic Dose |
1 |
36 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0528-37 |
Elevidys |
Per Therapeutic Dose |
1 |
37 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0529-38 |
Elevidys |
Per Therapeutic Dose |
1 |
38 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0530-39 |
Elevidys |
Per Therapeutic Dose |
1 |
39 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0531-40 |
Elevidys |
Per Therapeutic Dose |
1 |
40 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0532-41 |
Elevidys |
Per Therapeutic Dose |
1 |
41 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0533-42 |
Elevidys |
Per Therapeutic Dose |
1 |
42 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0534-43 |
Elevidys |
Per Therapeutic Dose |
1 |
43 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0535-44 |
Elevidys |
Per Therapeutic Dose |
1 |
44 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0536-45 |
Elevidys |
Per Therapeutic Dose |
1 |
45 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0537-46 |
Elevidys |
Per Therapeutic Dose |
1 |
46 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0538-47 |
Elevidys |
Per Therapeutic Dose |
1 |
47 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0539-48 |
Elevidys |
Per Therapeutic Dose |
1 |
48 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0540-49 |
Elevidys |
Per Therapeutic Dose |
1 |
49 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0541-50 |
Elevidys |
Per Therapeutic Dose |
1 |
50 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0542-51 |
Elevidys |
Per Therapeutic Dose |
1 |
51 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0543-52 |
Elevidys |
Per Therapeutic Dose |
1 |
52 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0544-53 |
Elevidys |
Per Therapeutic Dose |
1 |
53 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0545-54 |
Elevidys |
Per Therapeutic Dose |
1 |
54 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0546-55 |
Elevidys |
Per Therapeutic Dose |
1 |
55 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0547-56 |
Elevidys |
Per Therapeutic Dose |
1 |
56 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0548-57 |
Elevidys |
Per Therapeutic Dose |
1 |
57 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0549-58 |
Elevidys |
Per Therapeutic Dose |
1 |
58 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0550-59 |
Elevidys |
Per Therapeutic Dose |
1 |
59 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0551-60 |
Elevidys |
Per Therapeutic Dose |
1 |
60 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0552-61 |
Elevidys |
Per Therapeutic Dose |
1 |
61 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0553-62 |
Elevidys |
Per Therapeutic Dose |
1 |
62 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0554-63 |
Elevidys |
Per Therapeutic Dose |
1 |
63 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0555-64 |
Elevidys |
Per Therapeutic Dose |
1 |
64 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0556-65 |
Elevidys |
Per Therapeutic Dose |
1 |
65 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0557-66 |
Elevidys |
Per Therapeutic Dose |
1 |
66 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0558-67 |
Elevidys |
Per Therapeutic Dose |
1 |
67 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0559-68 |
Elevidys |
Per Therapeutic Dose |
1 |
68 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0560-69 |
Elevidys |
Per Therapeutic Dose |
1 |
69 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0561-70 |
Elevidys |
Per Therapeutic Dose |
1 |
70 |
1 |
1 |
J1426 |
Injection, casimersen, 10 mg |
Sarepta Therapeutics, Inc. |
60923-0227-02 |
Amondys 45 |
10 MG |
2 |
1 |
10 |
10 |
J1428 |
Inj, eteplirsen, 10 mg |
Sarepta Therapeutics, Inc. |
60923-0284-10 |
Exondys 51 |
10 MG |
10 |
1 |
50 |
50 |
J1428 |
Inj, eteplirsen, 10 mg |
Sarepta Therapeutics, Inc. |
60923-0363-02 |
Exondys 51 |
10 MG |
2 |
1 |
10 |
10 |
J1451 |
Fomepizole, 15 mg |
American Regent, Inc. |
00517-0710-01 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
Sagent Pharmaceuticals |
25021-0829-02 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
Mylan Institutional LLC |
67457-0211-02 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
Zydus Pharmaceuticals (USA) Inc. |
70710-1478-01 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1737 |
Inj meloxicam (azurity) 1mg |
Azurity Pharmaceuticals Inc. |
24338-0153-02 |
Xifyrm |
1 MG |
1 |
10 |
30 |
300 |
J1742 |
Ibutilide fumarate injection |
Pfizer Inc |
00009-3794-01 |
Corvert |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
Pfizer Inc |
00009-3794-22 |
Corvert |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
Heritage Pharmaceuticals Inc. |
23155-0326-31 |
Ibutilide Fumarate |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
Mylan Institutional LLC |
67457-0366-10 |
Ibutilide Fumarate |
1 MG |
10 |
1 |
1 |
1 |
J1807 |
Inj, ethacrynate sod, 1 mg |
Endo USA, Inc. |
42023-0157-01 |
Ethacrynate Sodium |
1 MG |
1 |
1 |
50 |
50 |
J1807 |
Inj, ethacrynate sod, 1 mg |
LEADING PHARMA LLC |
69315-0701-50 |
Ethacrynate Sodium |
1 MG |
1 |
1 |
50 |
50 |
J1833 |
Injection, isavuconazonium |
Astellas Pharma US, Inc. |
00469-0420-01 |
Cresemba |
1 MG |
1 |
1 |
372 |
372 |
J1834 |
Inj, isoniazid, 1 mg |
Sandoz Inc. |
00781-3056-70 |
Isoniazid Injection |
1 MG |
10 |
1 |
1000 |
1000 |
J2186 |
Inj., meropenem, vaborbactam |
Melinta Therapeutics, LLC |
70842-0120-06 |
Vabomere |
(10 MG/10MG) 20 MG |
1 |
6 |
100 |
600 |
J2265 |
Minocycline hydrochloride |
Melinta Therapeutics, LLC |
70842-0160-10 |
Minocin |
1 MG |
1 |
10 |
100 |
1000 |
J2326 |
Inj, nusinersen, 0.1mg |
Biogen Inc. |
64406-0058-01 |
Spinraza |
0.1 MG |
5 |
1 |
120 |
120 |
J2515 |
Pentobarbital sodium inj |
Hikma Pharmaceuticals USA Inc. |
24201-0010-20 |
Pentobarbital |
50 MG |
20 |
1 |
20 |
20 |
J2515 |
Pentobarbital sodium inj |
Hikma Pharmaceuticals USA Inc. |
24201-0010-50 |
Pentobarbital |
50 MG |
50 |
1 |
50 |
50 |
J2515 |
Pentobarbital sodium inj |
Sagent Pharmaceuticals |
25021-0676-20 |
Pentobarbital |
50 MG |
20 |
1 |
20 |
20 |
J2515 |
Pentobarbital sodium inj |
Sagent Pharmaceuticals |
25021-0676-50 |
Pentobarbital |
50 MG |
50 |
1 |
50 |
50 |
J2547 |
Injection, peramivir |
BioCryst Pharmaceuticals, Inc. |
72769-0181-03 |
Rapivab |
1 MG |
20 |
3 |
200 |
600 |
J2561 |
Inj, sezaby, 1 mg |
Sun Pharmaceutical Industries, Inc. |
62756-0301-01 |
Sezaby |
1 MG |
1 |
1 |
100 |
100 |
J2801 |
Inj, rykindo, 0.5 mg |
Luye Pharma USA Ltd |
72526-0101-11 |
Rykindo |
0.5 MG |
1 |
1 |
25 |
25 |
J2801 |
Inj, rykindo, 0.5 mg |
Luye Pharma USA Ltd |
72526-0102-11 |
Rykindo |
0.5 MG |
1 |
1 |
50 |
50 |
J2801 |
Inj, rykindo, 0.5 mg |
Luye Pharma USA Ltd |
72526-0103-11 |
Rykindo |
0.5 MG |
1 |
1 |
75 |
75 |
J2801 |
Inj, rykindo, 0.5 mg |
Luye Pharma USA Ltd |
72526-0104-11 |
Rykindo |
0.5 MG |
1 |
1 |
100 |
100 |
J2840 |
Inj sebelipase alfa 1 mg |
Alexion Pharmaceuticals, Inc. |
25682-0007-01 |
Kanuma |
1 MG |
10 |
1 |
20 |
20 |
J2850 |
Inj secretin synthetic human |
ChiRhoClin, Inc |
67066-0005-01 |
Chirhostim |
1 MCG |
1 |
1 |
16 |
16 |
J2998 |
Inj plasminogen tvmh 1mg |
Kedrion Biopharma Inc |
70573-0099-02 |
Ryplazim |
1 MG |
1 |
1 |
68.8 |
69 |
J3387 |
Inj elivaldogene autotemecel |
Bluebird Bio, Inc. |
73554-2111-01 |
Skysona |
Per Therapeutic Dose |
20 |
1 |
1 |
1 |
J3389 |
Topi adm prad zami per treat |
Abeona Therapeutics Inc. |
84103-0007-01 |
Zevaskyn |
Per Therapeutic Dose |
1 |
1 |
1 |
1 |
J3391 |
Inj, atidarsagene autotemcel |
Orchard Therapeutics Europe Limited |
83222-0200-01 |
Lenmeldy |
Per Treatment Dose |
1 |
1 |
1 |
1 |
J3392 |
Inj, exagamglogene autotem |
Vertex Pharmaceuticals, Inc. |
51167-0290-09 |
Casgevy |
Per Treatment |
1 |
1 |
1 |
1 |
J3393 |
Inj, betibeglogene autotemce |
Bluebird Bio, Inc. |
73554-3111-01 |
Zynteglo |
Per Therapeutic Dose |
20 |
1 |
1 |
1 |
J3394 |
Inj, lovotibeglogene autotem |
Bluebird Bio, Inc. |
73554-1111-01 |
Lyfgenia |
Per Treatment |
20 |
1 |
1 |
1 |
J3397 |
Inj., vestronidase alfa-vjbk |
Ultragenyx Pharmaceutical Inc. |
69794-0001-01 |
Mepsevii |
1 MG |
5 |
1 |
10 |
10 |
J3398 |
Inj luxturna 1 billion vec g |
Spark Therapeutics, Inc. |
71394-0415-01 |
Luxturna |
1 billion vector genomes |
0.5 |
1 |
150 |
150 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0120-02 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
16.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0121-03 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
19.3 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0122-03 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
22.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0123-03 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
24.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0124-04 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
27.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0125-04 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
30.4 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0126-04 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
33.2 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0127-05 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
35.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0128-05 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
38.7 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0129-05 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
41.5 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0130-06 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
44.2 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0131-06 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
47 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0132-06 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
49.8 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0133-07 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
52.5 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0134-07 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
55.3 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0135-07 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
58.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0136-08 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
60.8 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0137-08 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
63.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0138-08 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
66.4 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0139-09 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
69.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0140-09 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
71.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0141-09 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
74.7 |
1 |
1 |
1 |
J3404 |
Inj zopapogene per ther dose |
Precigen, Inc. |
84768-0511-01 |
Papzimeos |
Per Therapeutic Dose |
1 |
1 |
1 |
1 |
J3424 |
Inj hydroxocobalamin iv 25mg |
Meridian Medical Technologies LLC |
11704-0370-01 |
Cyanokit |
25 MG |
1 |
1 |
200 |
200 |
J3424 |
Inj hydroxocobalamin iv 25mg |
BTG International Inc. |
50633-0310-11 |
Cyanokit |
25 MG |
1 |
1 |
200 |
200 |
J7165 |
Inj, human-lans, per i.u |
Octapharma USA Inc. |
68982-0261-01 |
Balfaxar |
PER FACTOR IX IU |
1 |
1 |
1 |
1 |
J7165 |
Inj, human-lans, per i.u |
Octapharma USA Inc. |
68982-0261-02 |
Balfaxar |
PER FACTOR IX IU |
1 |
1 |
1 |
1 |
J7168 |
Prothrombin complex kcentra |
CSL Behring L.L.C. |
63833-0386-02 |
Kcentra |
1 IU |
1 |
1 |
1 |
1 |
J7168 |
Prothrombin complex kcentra |
CSL Behring L.L.C. |
63833-0387-02 |
Kcentra |
1 IU |
1 |
1 |
1 |
1 |
J7169 |
Inj andexxa, 10 mg |
AstraZeneca Pharmaceuticals LP |
00310-3200-04 |
Andexxa |
10 MG |
1 |
4 |
20 |
80 |
J7169 |
Inj andexxa, 10 mg |
AstraZeneca Pharmaceuticals LP |
00310-3200-05 |
Andexxa |
10 MG |
1 |
5 |
20 |
100 |
J7352 |
Afamelanotide implant, 1 mg |
Clinuvel Inc. |
73372-0116-01 |
Scenesse |
1 MG |
1 |
1 |
16 |
16 |
J7501 |
Azathioprine parenteral |
Hikma Pharmaceuticals USA Inc. |
00143-9566-01 |
Azathioprine |
100 MG |
1 |
1 |
1 |
1 |
J9174 |
Inj, docetaxel (beizray) 1mg |
Zydus Pharmaceuticals (USA) Inc. |
70710-2091-03 |
Beizray |
1 MG |
4 |
1 |
80 |
80 |
J9174 |
Inj, docetaxel (beizray) 1mg |
Zydus Pharmaceuticals USA Inc |
70710-2092-08 |
Beizray |
1 MG |
1 |
1 |
20 |
20 |
J9174 |
Inj, docetaxel (beizray) 1mg |
Zydus Pharmaceuticals (USA) Inc. |
70710-2093-04 |
Beizray |
1 MG |
4 |
2 |
80 |
160 |
J9220 |
Indigotindisulfonate sod 1mg |
Apollo Pharmaceuticals |
81284-0315-05 |
Bludigo |
1 MG |
5 |
5 |
40 |
200 |
J9275 |
Inj cosibelimab-ipdl, 2 mg |
Checkpoint Therapeutics Inc |
83444-0301-10 |
Unloxcyt |
2 MG |
5 |
1 |
150 |
150 |
J9302 |
Ofatumumab injection |
Novartis Pharmaceuticals Corporation |
00078-0669-13 |
Arzerra |
10 MG |
5 |
3 |
10 |
30 |
J9302 |
Ofatumumab injection |
Novartis Pharmaceuticals Corporation |
00078-0690-61 |
Arzerra |
10 MG |
50 |
1 |
100 |
100 |
J9313 |
Inj., lumoxiti, 0.01 mg |
AstraZeneca Pharmaceuticals LP |
73380-4700-01 |
Lumoxiti |
0.01 MG |
1 |
1 |
100 |
100 |
J9376 |
Inj pozelimab-bbfg, 1 mg |
Regeneron Pharmaceuticals, Inc. |
61755-0014-01 |
Veopoz |
1 MG |
2 |
1 |
400 |
400 |
Q2009 |
Fosphenytoin inj pe |
Pfizer Inc |
00069-5471-02 |
Cerebyx |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj pe |
Pfizer Inc |
00069-5474-02 |
Cerebyx |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj pe |
Pfizer Inc |
00069-6001-21 |
Cerebyx |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj pe |
Pfizer Inc |
00069-6001-25 |
Cerebyx |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj pe |
Hikma Pharmaceuticals USA Inc. |
00641-6136-25 |
Fosphenytoin Sodium |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj pe |
Sagent Pharmaceuticals |
25021-0798-02 |
Fosphenytoin Sodium |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj pe |
Sagent Pharmaceuticals |
25021-0798-10 |
Fosphenytoin Sodium |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj pe |
FreseniUS Kabi USA, LLC |
63323-0403-02 |
Fosphenytoin Sodium |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj pe |
FreseniUS Kabi USA, LLC |
63323-0403-10 |
Fosphenytoin Sodium |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj pe |
Glenmark Pharmaceuticals Inc., USA |
68462-0621-54 |
Fosphenytoin Sodium |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj pe |
Glenmark Pharmaceuticals Inc., USA |
68462-0622-64 |
Fosphenytoin Sodium |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2058 |
Obecbtge autol up to 400 mil |
Autolus, Inc |
83047-0410-04 |
Aucatzyl |
Per Therapeutic Dose |
1 |
1 |
1 |
2 |
Q5160 |
Inj, jobevne, 10 mg |
Biocon Biologics Inc. |
83257-0009-11 |
Jobevne |
10 MG |
4 |
1 |
10 |
10 |
Q5160 |
Inj, jobevne, 10 mg |
Biocon Biologics Inc. |
83257-0010-11 |
Jobevne |
10 MG |
16 |
1 |
40 |
40 |
Q9968 |
Visualization adjunct |
Mylan Institutional LLC |
67457-0220-05 |
Isosulfan Blue |
1 MG |
5 |
6 |
50 |
300 |
Q9968 |
Visualization adjunct |
American Regent, Inc. |
00517-0374-05 |
Provayblue |
1 MG |
10 |
5 |
50 |
250 |
Q9982 |
Flutemetamol f18 diagnostic |
GE Healthcare Inc. |
17156-0067-30 |
Vizamyl |
Per Study Dose, up to 5 millicuries |
1 |
1 |
1 |
1 |
Q9983 |
Florbetaben f18 diagnostic |
Lantheus Medical Imaging, Inc. |
54828-0001-50 |
Neuraceq |
PER STUDY DOSE, UPTO 8 mCi |
50 |
1 |
1 |
1 |